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In 1993, a research group was established at the department of Medical 
Informatics, Epidemiology and Bio-statistics of the University of Nijmegen, 
for studies in the field of health care technology assessment. It was a joint 
initiative of the University Hospital St Radboud and the Medical Faculty 
of the University. From the outset, the originators have emphasized that 
this research group should pay specific attention to analysing ethical and 
social aspects of health care technologies. Professor Henk ten Have was 
one of the originators, and he is among the few who have published in this 
area (ten Have, 1995). Health care technology assessment is usually 
defined as analysis of the medical, economic, social, ethical and legal 
impact of health care technology (see for instance Banta and Luce, 1993). 
In practice, however, emphasis is usually on medical and economic aspects 
(cost-effectiveness analysis), while other issues are relatively neglected. The 
mission of the Nijmegen medical technology assessment group was, and is, 
to pay more attention to the ethical, social, and legal issues when analys­
ing the value of health care technologies.In the following, I will briefly 
describe how we try to establish this objective. I will start by describing a 
specific case, the assessment of cochlear implants in young deaf children.
A cochlear implant is a device which can give totally deaf children a 
certain hearing sensation. It works by relaying electrical signals, generated
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by sound, directly to the acoustic nerve. The technology has been devel­
oped some decades ago, and has been the object of several evaluation 
studies. These studies have focused on the safety and efficacy of the device. 
Children who had received an implant were tested for their ability to 
produce understandable oral speech and for their ability to understand 
spoken language. In addition, several cost analyses have been caried out. 
Without exception, these studies conclude that the cochlear implant is a 
safe, and cost-effective device. The social controversies surrounding 
cochlear implants in deaf children are usually mentioned in passing, if at 
all. These controversies resulted chiefly from the fact that deaf adults 
considered cochlear implants as a threat to deaf culture. They also viewed 
cochlear implants as yet another sign of the hearing community that it 
considers deaf culture and communication in sign language as inferior. 
They maintain that deaf children with a cochlear implant remain deaf 
children, and that the huge resources that are spent on cochlear implants 
should not be withdrawn from services for the deaf (special education, 
courses in sign language etc.). Parents of deaf children are concerned that 
implanted children may be neither deaf, nor hearing. Instead of having the 
best of two worlds, they may end up with nothing at all.
What we see here, is that the social issues were largely ignored in health 
care technology assessments. As such, there was a certain bias in these 
studies, favouring the technology. A group of stakeholders has not succeed­
ed in getting access to the research agenda of health technology assess­
ment. They have not been able in translating their concerns into research 
questions, addressed in the various studies. The result is that policy 
decisions on cochlear implants have to be based on a number of facts 
regarding safety and cost-effectiveness and on a number of ’other issues’ 
that have not been examined with the same rigour. As such, these ’other 
issues’ are unlikely to have a substantial impact on the decion making 
process, and uncertainties and concerns in this respect are likely to persist. 
Inadvertently, then, health care technology assessment may reinforce 
existing inequities in these decision making processes. ’Other issues’ are 
likely to remain ’end of the day considerations’.
24 European Philosophy of Medicine and Health Care 4:2,1996
e u r o p e a n  r e s e a r c h
Generally speaking, by analyzing examples such as the one above, we try to 
argue that health care technology assessment is not a matter of collecting 
the facts about a technology, but a matter of collecting facts that are 
relevant, given a particular value framework. As we all know, these value 
frameworks need not be shared by all parties involved. In the practice of 
health care technology assessment, this is reflected in differences in 
problem definition, in identification of feasible and acceptable solutions, 
and in defining criteria for evaluation, many health care technology 
assessments finally end up with a cost utility ratio of a health service. Only 
rarely, the utilitarian underpinnings of this are mentioned explicitly. The 
rich analyses on pros and cons of ethical utilitarian theory (e.g. the as­
sumptions of commensurability and aggregation) rarely enter the field of 
health care technology assessment. Adopting a different conception of 
justice (e.g. the rawlsian theory of justice as applied to health care by 
Norman Daniels) would require collection of qualitatively different data on 
the use of health care technology.
Fortunately, due to the influence of leading professionals in the field of 
health care technology assessment such as David Banta, the appreciation of 
the value of ethical analysis is gaining acceptance. Last year, during the 
annual meeting of the International society of Technology assesment in 
health Care, we were given the opportunity to organize a workshop on 
ethical issues in technology assessment. Contributions of Andrew Edgar 
(Cardiff), Stuart Blume (Amsterdam), Medard Hilhorst (Rotterdam) and 
Heitman (Houston) met with considerable enthousiasm. Yet, much needs 
to be done, not in the least in the field of methodology. Also, and this is 
only understandable, clinicians are sometimes reluctant to cooperate when 
it comes to ethical issues. Frequently, ’ethical issues’ are identified with 
’negative, adverse effects’. Although this may be the case, this need not be 
so. I feel that here, the misconceived fact-value dichotomy takes its toll.
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RESEARCH PROJECTS
A  study of the definition of 'medical necessity’
This is the central theme of a EC-BIOMED project ’Limiting access to 
health care in various European countries’. It is also a central theme of a 
research grant which was recently submitted to the Dutch Organization of 
Scientific Research (NWO), together with Hilhorst (Erasmus University 
Rotterdam, and Grin, University of Amsterdam). We try to incorporate the 
findings of projects like these into the evaluation projects that are carried 
out in the University Hospital.
’Eurassess’. This is a research project, co-ordinated by prof. dr. David 
Banta from TNO Leiden, and funded by the European BIOMED program­
me. In the methods subgroup, chaired by prof.dr. Trevor Shelden from 
York, we have contributed by developing methods for assessing social and 
ethical aspects in health care technology assessment.
The other participants to this EC-project are:
Bengt Brorrson, Swedish Council for Health Care Technology Assessment, 
Stockholm, Sweden; Frederick Fleurette, ANDEM, Paris, France; Torben 
Jorgensen, Danish Hospital Institute, Denmark; Albert Jovell, Departa- 
ment de Sanitat I Seguretat Social, Barcelona, Spain; Jim Kahan, 
RAND/European-American Center for Policy Analysis, The Netherlands; 
Alessandro Liberati, Instituto Mario Negri, Italy; Trevor Sheldon, NHS 
Centre for Reviews and Dissemination, University of York, England; Harri 
Sintonen, Department of Health Policy and Management, University of 
Kuopio, Finland; Gabriel ten Velden, Health Council of the Netherlands, 
The Netherlands.
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■j The social context of health care technology assessment
In the context of this project, we analyzed the case of assessing cochlear 
implants in deaf children. We submitted a grant to the university of 
Nijmegen to continue this project.
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STAFF
The MTA group presently consists of seven researchers; two of them have
had a training in philosophy and ethics (van der Wilt and Reuzel).
\
COOPERATION WITH OTHER RESEARCH GROUPS
We have been fortunate in getting a grant from the European Community 
(EC-BIOMED programme), which allows us to cooperate with the follow­
ing people and organizations: 
dr. O.F. Norheim, Institute of Medical Ethics, Oslo 
prof. dr. E. van Leeuwen and drs. S. van de Vathorst, Vrije Universiteit, 
Amsterdam
dr. P. Rossel and dr. S. Holm, Institute of Theoretical Medicine, {Copen­
hagen
dr. Andrew Edgar, Institute for Ethics, Cardiff
prof. dr. H.M. Sass, Bochum / Kennedy Institute of Ethics.
Prof. dr. Norman Daniels from Tufst University, Boston, US, has kindly 
accepted to act as a consultant to this project.
The Hastings Centre has been very hospitable, also to us; especially dr. 
Philip Boyle’s research project on Technology assesment in hospitals is of 
great interest to us.
Finally, we cooperate with the MTA-unit of TNO, Leiden (prof. dr. H. 
David banta, dr. T. van Beekum, drs. W. Oortwijn), to further operationa­
lize the concept of interactive technology assessment (as described for 
instance by Guba and Lincoln, in Fourth Generation Evaluation, Sage, 
1989).
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